Serial 79416311
Live / Registered — Registered (as of 23 Dec 2025)
What this means for you
Registered since 23 Dec 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79416311
- Registration number
- 8072839
- Mark type
- Design / logo
- Filed
- 02 Dec 2024
- Published for opposition
- 04 Nov 2025
- Registered
- 23 Dec 2025
- Attorney of record
- Keith R. Obert
Goods and services
- Class 005 — Pharmaceuticals: Tumor suppressing agents; vaccines; reagent paper for medical purposes; immunostimulants; adjuvants for medical purposes; diagnostic preparations for medical purposes
- Class 042 — Scientific and technological services: Research and development of vaccines and medicines; vaccine research and development services; research and development services relating to medicines; consultancy relating to pharmaceutical research and development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; pharmaceutical product evaluation; medical research; biological research; scientific research; research and development of new products for others
Owner
- DeCUROS Co., Ltd., JP
- DeCUROS Co., Ltd., JP
- DeCUROS Co., Ltd., JP
Prosecution history
- 23 Mar 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 23 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
- 04 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Nov 2025 — PUBLISHED FOR OPPOSITION
- 29 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Aug 2025 — REFUSAL PROCESSED BY IB
- 24 Jul 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 24 Jul 2025 — REFUSAL PROCESSED BY MPU
- 30 May 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 29 May 2025 — NON-FINAL ACTION WRITTEN